Page 283 - Vitamin D and Cancer

270 R. Okamoto et al.

15. Wang X, Studzinski GP (Apr 15,2006) The requirement for and changing composition of the
activating protein-1 transcription factor during differentiation of human leukemia HL60 cells
induced by 1,25-dihydroxyvitamin D3. Cancer Res 66(8):4402–9
16. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC (Sep 16,1983) 1,25-dihydroxyvita-
min D3 receptors in human leukocytes. Science 221(4616):1181–3
17. Veldman CM, Cantorna MT, DeLuca HF (Feb 15,2000) Expression of 1,25-dihydroxyvita-
min D(3) receptor in the immune system. Arch Biochem Biophys 374(2):334–8
18. Morgan JW, Sliney DJ, Morgan DM, Maizel AL (Jan,1999) Differential regulation of gene
transcription in subpopulations of human B lymphocytes by vitamin D3. Endocrinology
140(1):38 1–91
19. Iho S, Takahashi T, Kura F, Sugiyama H, Hoshino T (June 15, 1986) The effect of
1,25- dihydroxyvitamin D3 on in vitro immunoglobulin production in human B cells. J Immunol
1 36(12):4427–31
20. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC (May, 1985)
1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro.
J Immunol 134(5):3032–5
21. Rigby WF, Stacy T, Fanger MW (Oct, 1984) Inhibition of T lymphocyte mitogenesis by
1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 74(4):1451–5
22. Tsoukas CD, Provvedini DM, Manolagas SC (June 29, 1984) 1,25-dihydroxyvitamin D3: a
novel immunoregu1atory hormone. Science 224(4656):1438–40
23. Reichel H, Koeffler HP, Tobler A, Norman AW (May, 1987) 1 alpha,25-Dihydroxyvitamin
D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes.
Proc Natl Acad Sci USA 84(10):3385–9
24. Tobler A, Miller CW, Norman AW, Koeffler HP (June 1988) 1,25-Dihydroxyvitamin D3
modulates the expression of a lymphokine (granulocyte-macrophage colony-stimulating
factor) posttranscriptionally. J Clin Invest 81(6):1819–23
25. Soldati L, Adamo D, Bianchin C, Arcidiacono T, Terranegra A, Bianchi ML, Mora S, Cusi
D, Vezzoli G (Aug, 2004) Vitamin D receptor mRNA measured in leukocytes with the
TaqMan fluorogenic detection system: effect of calcitriol administration. Clin Chem
50(8):1315–21
26. Manolagas SC, Werntz DA, Tsoukas CD, Provvedini DM, Vaughan JH (Dec, 1986)
1,25-Dihydroxyvitamin D3 receptors in lymphocytes from patients with rheumatoid arthritis.
J Lab Clin Med 108(6):596–600
27. Provvedini DM, Rulot CM, Sobol RE, Tsoukas CD, Manolagas SC (June 1987) 1 alpha,25-
Dihydroxyvitamin D3 receptors in human thymic and tonsillar lymphocytes. J Bone Miner
Res 2(3):239–47
28. Biyoudi-Vouenze R, Cadranel J, Valeyre D, Milleron B, Hance AJ, Soler P (June 1991)
Expression of 1,25(0H)2D3 receptors on alveolar lymphocytes from patients with pulmonary
granulomatous diseases. Am Rev Respir Dis 143(6):1376–80
29. Hickish T, Cunningham D, Colston K, Millar BC, Sandle J, Mackay AG, Soukop M, Sloane
J (Oct, 1993) The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression
of vitamin D receptor in lymphoma. Br J Cancer 68(4):668–72
30. O’Kelly J, Hisatake J, Hisatake Y, Bishop J, Norman A, Koeffler HP (Apr, 2002) Normal
myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice.
J Clin Invest 109(8):1091–9
31. Yu S, Cantorna MT (Apr 1, 2008) The vitamin D receptor is required for iNKT cell develop-
ment. Proc Natl Acad Sci USA 105(13):5207–12
32. Koeffler HP, Amatruda T, Ikekawa N, Kobayashi Y, DeLuca HF (Dec, 1984) Induction
of macrophage differentiation of human normal and leukemic myeloid stem cells by
1,25- dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res 44(12 Pt 1):
5624–8
33. Provvedini DM, Deftos LJ, Manolagas SC (1986) 1,25-Dihydroxyvitamin D3 promotes
in vitro morphologic and enzymatic changes in normal human monocytes consistent with
their differentiation into macrophages. Bone 7(1):23–8